The researchers found that they were able to take the immature testicular tissue containing these stem cells and cryopreserve them. After treating the primate group with chemotherapy, the tissue was thawed and grafted back under the skin of the animal it came from. The animals then entered puberty, and after they reached maturity were checked to see if the process had been successful. Researchers found that significant amounts of sperm had been produced, so they collected it and sent it to another lab where they were used to create viable embryos and then implanted in surrogate mothers. One of these resulted in the birth of a female named “Grady.”
Researchers hope that the work they have done will allow survivors of childhood cancer to regain fertility that may have been lost as a result of treatments. The lead author, Kyle Orwig, explained, “This advance is an important step toward offering young cancer patients around the world a chance at having a family in the future.”
If you found this article interesting, consider looking into INVO Bioscience (IVOB), a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Their solution, the INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. Their mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase the availability of care. You can find more information at their dedicated page on our website.